- Companies
- Meds Apotek
Meds Apotek Valuation Multiples
Meds Apotek is valued at $45M as of September 2026, a 0.3x revenue multiple. In the last 12 months, Meds Apotek revenue was $113M and Meds Apotek EBITDA was $4M.
Meds Apotek Overview
About Meds Apotek
Meds Apotek AB (publ) is a full-scale online pharmacy that sells prescription and over-the-counter medicines with permission from the Swedish Medicines Agency. The company's pharmacy products include everything in health, well-being, dietary supplements, beauty, skin care, and animal medicines.
Founded
2017
HQ
Employees
N/A
Website
Financials (LTM)
EV
$38M
Valuation Multiples
Start free trialMeds Apotek Financials
Meds Apotek reported last 12-month revenue of $113M and EBITDA of $4M.
In the same LTM period, Meds Apotek generated $17M in gross profit, $4M in EBITDA, and $2M in net income.
Revenue (LTM)
Meds Apotek P&L
In the most recent fiscal year, Meds Apotek reported revenue of $101M and EBITDA of $2M.
Meds Apotek is profitable as of last fiscal year, with gross margin of 28%, EBITDA margin of 2%, and net margin of 1%.
Financial data powered by Morningstar, Inc.
Meds Apotek Stock Performance
Meds Apotek has current market cap of $45M, and enterprise value of $38M.
Market Cap Evolution
Meds Apotek's stock price is $2.42.
Meds Apotek share price decreased by 8.2% in the last 30 days.
Meds Apotek has an EPS (earnings per share) of $0.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $38M | $45M | -1.6% | -8.2% | - | - | $0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMeds Apotek Valuation Multiples
Meds Apotek trades at 0.3x EV/Revenue multiple, and 9.2x EV/EBITDA.
EV / Revenue (LTM)
Meds Apotek Financial Valuation Multiples
As of September 30, 2026, Meds Apotek has market cap of $45M and EV of $38M.
Meds Apotek has a P/E ratio of 29.2x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Meds Apotek Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Meds Apotek Margins & Growth Rates
Meds Apotek grew revenue by 12% and EBITDA by 136% in the last fiscal year.
In the most recent fiscal year, Meds Apotek reported gross margin of 28%, EBITDA margin of 2%, and net margin of 1%.
Meds Apotek Margins
Meds Apotek Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Meds Apotek Operational KPIs
Meds Apotek's Rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Meds Apotek's Rule of X is 34% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Meds Apotek Competitors
Meds Apotek competitors include Grove Collaborative, Miratap, Sportsman's Warehouse, SunCar, Mister Spex, Koukandekirukun, Angling Direct, Autopedia, Yoho Group Holdings and CMON.
Most Meds Apotek public comparables operate across Pharmacies, Consumer E-commerce and Vertical E-commerce.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $174M | ($9M) | 0.5x | 0.5x | (9.2x) | 40.2x | |||
| $106M | ($3M) | 0.5x | 0.5x | (18.6x) | - | |||
| $1.2B | $2M | 0.4x | 0.4x | 319.2x | 17.5x | |||
| $489M | $9M | 0.3x | 0.3x | 17.0x | 8.5x | |||
| $206M | ($5M) | 0.3x | 0.3x | (12.1x) | (7.9x) | |||
| $80M | $2M | 0.5x | 0.5x | 22.7x | - | |||
| $138M | $10M | 0.4x | 0.4x | 4.8x | 5.0x | |||
| $56M | $5M | 0.4x | - | 5.2x | - | |||
This data is available for Pro users. Sign up to see all Meds Apotek competitors and their valuation data. Start Free Trial | ||||||||
Meds Apotek VC Funding History
Before going public, Meds Apotek raised $46M in total equity funding, across 5 rounds.
Meds Apotek Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Meds Apotek
| When was Meds Apotek founded? | Meds Apotek was founded in 2017. |
| Where is Meds Apotek headquartered? | Meds Apotek is headquartered in Sweden. |
| Is Meds Apotek publicly listed? | Yes, Meds Apotek is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Meds Apotek? | Meds Apotek trades under MEDS ticker. |
| When did Meds Apotek go public? | Meds Apotek went public in 2022. |
| Who are competitors of Meds Apotek? | Meds Apotek main competitors include Grove Collaborative, Miratap, Sportsman's Warehouse, SunCar, Mister Spex, Koukandekirukun, Angling Direct, Autopedia, Yoho Group Holdings, CMON. |
| What is the current market cap of Meds Apotek? | Meds Apotek's current market cap is $45M. |
| What is the current revenue of Meds Apotek? | Meds Apotek's last 12 months revenue is $113M. |
| What is the current revenue growth of Meds Apotek? | Meds Apotek revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of Meds Apotek? | Current revenue multiple of Meds Apotek is 0.3x. |
| What is the current EBITDA of Meds Apotek? | Meds Apotek's last 12 months EBITDA is $4M. |
| What is Meds Apotek's EBITDA margin? | Meds Apotek's last 12 months EBITDA margin is 4%. |
| What is the current EV/EBITDA multiple of Meds Apotek? | Current EBITDA multiple of Meds Apotek is 9.2x. |
| What is the current FCF of Meds Apotek? | Meds Apotek's last 12 months FCF is $2M. |
| What is Meds Apotek's FCF margin? | Meds Apotek's last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of Meds Apotek? | Current FCF multiple of Meds Apotek is 24.0x. |
| How many companies Meds Apotek has acquired to date? | Meds Apotek hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Meds Apotek has invested to date? | Meds Apotek hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Meds Apotek
Lists including Meds Apotek
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




